Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta‐analysis

作者: E.V. Lemos , F.P. de la Hoz , T.R. Einarson , W.F. McGhan , E. Quevedo

DOI: 10.1111/1469-0691.12363

关键词:

摘要: Acinetobacter baumannii has emerged as a major cause of healthcare-associated infections. Controversy exists to whether antimicrobial resistance increases the risk mortality. We conducted systematic review and meta-analysis examine this association. searched MEDLINE EMBASE databases up May 2013 identify studies comparing mortality in patients with carbapenem-resistant A. (CRAB) vs. carbapenem-susceptible (CSAB). A random-effects model was used pool Odds Ratios (OR). Heterogeneity examined using I(2). included 16 observational studies. There were 850 reported deaths (33%) among 2546 patients. Patients CRAB had significantly higher than CSAB pooled analysis crude effect estimates (crude OR = 2.22; 95% CI 1.66, 2.98), although substantial heterogeneity evident (heterogeneity I(2) 55%). The association remained significant adjusted 10 Studies that compared more likely have severe underlying illness also receive inappropriate empirical treatment, which Our study suggests carbapenem may increase infection. However, cautious interpretation is required because residual confounding factors inadequate sample size most

参考文章(32)
Silom Jamulitrat, Pranee Arunpan, Parichart Phainuphong, Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection. Journal of the Medical Association of Thailand Chotmaihet thangphaet. ,vol. 92, pp. 413- ,(2009)
Piskin N, Akduman D, Oztoprak N, Keskin As, Celebi G, Aydemir H, Aktas E, Sumbuloglu, Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital. Japanese Journal of Infectious Diseases. ,vol. 65, pp. 66- 71 ,(2012)
E.V. Lemos, F.P. de la Hoz, N. Alvis, T.R. Einarson, E. Quevedo, C. Castañeda, Y. Leon, C. Amado, O. Cañon, K. Kawai, Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia Clinical Microbiology and Infection. ,vol. 20, pp. 174- 180 ,(2014) , 10.1111/1469-0691.12251
Colin B. Begg, Madhuchhanda Mazumdar, Operating characteristics of a rank correlation test for publication bias. Biometrics. ,vol. 50, pp. 1088- 1101 ,(1994) , 10.2307/2533446
Zakuan Zainy Deris, Mohd Nazri Shafei, Azian Harun, Risk factors and outcomes of imipenem-resistant Acinetobacter bloodstream infection in North-eastern Malaysia Asian pacific Journal of Tropical Biomedicine. ,vol. 1, pp. 313- 315 ,(2011) , 10.1016/S2221-1691(11)60050-6
Shih-Tse Huang, Mei-Chun Chiang, Shu-Chen Kuo, Yi-Tzu Lee, Tong-Hong Chiang, Su-Pen Yang, Ti-Yin, Te-Li Chen, Chang-Phone Fung, Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia Journal of Microbiology, Immunology and Infection. ,vol. 45, pp. 356- 362 ,(2012) , 10.1016/J.JMII.2011.12.009
M. E. FALAGAS, E. A. KARVELI, I. I. SIEMPOS, K. Z. VARDAKAS, Acinetobacter infections: a growing threat for critically ill patients. Epidemiology and Infection. ,vol. 136, pp. 1009- 1019 ,(2008) , 10.1017/S0950268807009478
D. W. Wareham, D. C. Bean, P. Khanna, E. M. Hennessy, D. Krahe, A. Ely, M. Millar, Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 27, pp. 607- 612 ,(2008) , 10.1007/S10096-008-0473-Y
Gokhan Metan, Fatma Sariguzel, Bulent Sumerkan, Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia. European Journal of Internal Medicine. ,vol. 20, pp. 540- 544 ,(2009) , 10.1016/J.EJIM.2009.05.005